Home

autobus Berri vena maria rosa pozzi reumatologa Situazioni non prevedibili Gonfiare Indefinito

pillole di casi clinici e non solo
pillole di casi clinici e non solo

Phenotypes Determined by Cluster Analysis and Their Survival in the  Prospective European Scleroderma Trials and Research Cohort
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort

Malattie reumatiche: 2°edizione dell'(H)Open day di Onda alla ASST di Monza  - MBNews
Malattie reumatiche: 2°edizione dell'(H)Open day di Onda alla ASST di Monza - MBNews

Patient preferences in the choice of anti-TNF therapies in rheumatoid  arthritis. Results from a questionnaire survey (RIVIERA study)
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study)

Gli specialisti - Medicina e Informazione Web Tv
Gli specialisti - Medicina e Informazione Web Tv

Maria POZZI | MD | Internal medicine
Maria POZZI | MD | Internal medicine

Sclerodermia, giornata di visite gratuite all'ospedale San Gerardo di Monza  - Il Cittadino di Monza e Brianza
Sclerodermia, giornata di visite gratuite all'ospedale San Gerardo di Monza - Il Cittadino di Monza e Brianza

Predictors of disease worsening defined by progression of organ damage in  diffuse systemic sclerosis: a European Scleroderma Trials and Research  (EUSTAR) analysis | Annals of the Rheumatic Diseases
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis | Annals of the Rheumatic Diseases

Predictors of disease worsening defined by progression of organ damage in  diffuse systemic sclerosis: a European Scleroderma Trials and Research  (EUSTAR) analysis | Annals of the Rheumatic Diseases
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis | Annals of the Rheumatic Diseases

POZZI Maria Rosa
POZZI Maria Rosa

scientifica
scientifica

Maria POZZI | MD | Internal medicine
Maria POZZI | MD | Internal medicine

Untitled
Untitled

Nome e Cognome/ Denominazione Operatori sanitari: Città dove si svolge  prevalentemente la professione Organi
Nome e Cognome/ Denominazione Operatori sanitari: Città dove si svolge prevalentemente la professione Organi

scientifica
scientifica

Valentina Varisco - Medico Reumatologo - Humanitas Gavazzeni e Castelli |  LinkedIn
Valentina Varisco - Medico Reumatologo - Humanitas Gavazzeni e Castelli | LinkedIn

Responsabile Struttura Semplice di Reumatologia - ppt scaricare
Responsabile Struttura Semplice di Reumatologia - ppt scaricare

Progressive skin fibrosis is associated with a decline in lung function and  worse survival in patients with diffuse cutaneous systemic sclerosis in the  European Scleroderma Trials and Research (EUSTAR) cohort | Annals
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort | Annals

Responsabile Struttura Semplice di Reumatologia - ppt scaricare
Responsabile Struttura Semplice di Reumatologia - ppt scaricare

Reumatologia
Reumatologia

PDF) Digital ulcers predict a worse disease course in patients with  systemic sclerosis | S. Zeni - Academia.edu
PDF) Digital ulcers predict a worse disease course in patients with systemic sclerosis | S. Zeni - Academia.edu

Due specializzandi del San... - Azienda Usl di Piacenza | Facebook
Due specializzandi del San... - Azienda Usl di Piacenza | Facebook

30 Giugno 2016 Nome e Cognome/ Denominazione Operatori sanitari: Città dove  si svolge prevalentemente la professione Organizz
30 Giugno 2016 Nome e Cognome/ Denominazione Operatori sanitari: Città dove si svolge prevalentemente la professione Organizz

marta riva - Medico specialista in reumatologia - Humanitas Gavazzeni e  Castelli | LinkedIn
marta riva - Medico specialista in reumatologia - Humanitas Gavazzeni e Castelli | LinkedIn

Phenotypes Determined by Cluster Analysis and Their Survival in the  Prospective European Scleroderma Trials and Research Cohort
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort

MALATTIA DI CASTLEMAN
MALATTIA DI CASTLEMAN